Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yang, C. W.
Right arrow Articles by Huang, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, C. W.
Right arrow Articles by Huang, C. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1996) 11: 2466-2471
© 1996 European Renal Association-European Dialysis and Transplant Association


research-article

Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis

C. W. Yang1,, T. L. Hwang2, C. H. Wu1, M. S. Wu1, P. C. Lai1, J. Y. Huang1, C. C. Yu1, M. H. Shyr3 and C. C. Huang1

1Division of Nephrology, Chang-Gung Memorial Hospital Taipei, Taiwan, Republic of China 2Department of Surgery, Chang-Gung Memorial Hospital Taipei, Taiwan, Republic of China 3Department of Anesthesia, Chang-Gung Memorial Hospital Taipei, Taiwan, Republic of China

Correspondence and offprint requests to: Correspondence and offprint requests to: Chih-Wei Yang, M. D., Associate Professor, Division of Nephrology, Chang-Gung Memorial Hospital, 199 Tun-Hwa North Road, Taipei 105, Taiwan, ROC

Nitric oxide plays an important role in mediating the inflammatory process. The aim of this study was to evaluate if nitric oxide production was increased during peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD), and the association with the prognosis. The study population comprised 21 patients with 22 episodes of peritonitis. Fifteen patients without peritonitis were controls. Nitrate was measured by HPLC and nitrite by the Griess method, to reflect nitric oxide production. Peritoneal dialysate effluent and plasma were collected from six patients during peritonitis and 1 week after treatment to study changes in dialysate:plasma ratio. In 15 patients, nitrite was measured during peritonitis and every 3 days for 2 weeks or until normalized for evolutional changes. The dialysate plasma ratios of nitrate and nitrite during peritonitis were reduced 26% and 41.5%, respectively, after 1 week of treatment, indicating the peritoneal production of nitric oxide during peritonitis. In the evolutional study, a 5.1-fold increase of peak nitrite levels in bacterial peritonitis (n=13) and a 2.5-fold increase in fungal peritonitis (n=3) were observed compared to controls. Nitrite gradually declined to control levels (9.3±7.2 days) after effective antibiotic treatment, but took longer than to normalize leukocyte count in the peritoneal dialysate effluent (3.9±1.9 days). In four patients with refractory peritonitis (Candida infection in three, Acinetobacter infection in one), the nitrite levels remained elevated 2-fold despite treatment, and the catheters were removed. It is concluded that nitrite levels in peritoneal dialysate effluent may serve as a marker to assess treatment efficacy in CAPD patients with peritonitis.

Keywords: continuous ambulatory peritoneal dialysis; nitric oxide; peritonitis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
pdiHome page
D. Lang and P. E. James
FREE NITRIC OXIDE IN SPENT CAPD FLUID: A LEAP OF FAITH?
Perit. Dial. Int., September 1, 2009; 29(5): 505 - 507.
[Full Text] [PDF]


Home page
pdiHome page
S. Mochizuki, A. Takayama, T. Sasaki, H. Horike, N. Kashihara, Y. Ogasawara, F. Kajiya, T. Kitawaki, and H. Oka
Direct Measurement of Nitric Oxide Concentration in CAPD Dialysate
Perit. Dial. Int., January 1, 2009; 29(1): 111 - 114.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Penders, T. Fiers, A. M. Dhondt, G. Claeys, and J. R. Delanghe
Automated flow cytometry analysis of peritoneal dialysis fluid
Nephrol. Dial. Transplant., February 1, 2004; 19(2): 463 - 468.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Ni, P. Moulin, P. Gianello, O. Feron, J.-L. Balligand, and O. Devuyst
Mice that Lack Endothelial Nitric Oxide Synthase Are Protected against Functional and Structural Modifications Induced by Acute Peritonitis
J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3205 - 3216.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. COMBET, T. MIYATA, P. MOULIN, D. POUTHIER, E. GOFFIN, and O. DEVUYST
Vascular Proliferation and Enhanced Expression of Endothelial Nitric Oxide Synthase in Human Peritoneum Exposed to Long-Term Peritoneal Dialysis
J. Am. Soc. Nephrol., April 1, 2000; 11(4): 717 - 728.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. COMBET, M. VAN LANDSCHOOT, P. MOULIN, A. PIECH, J.-M. VERBAVATZ, E. GOFFIN, J.-L. BALLIGAND, N. LAMEIRE, and O. DEVUYST
Regulation of Aquaporin-1 and Nitric Oxide Synthase Isoforms in a Rat Model of Acute Peritonitis
J. Am. Soc. Nephrol., October 1, 1999; 10(10): 2185 - 2196.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
O. Devuyst, S. Nielsen, J.-P. Cosyns, B. L. Smith, P. Agre, J.-P. Squifflet, D. Pouthier, and E. Goffin
Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum
Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H234 - H242.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.